$502 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 50 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 86.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLF | Sell | SELECT SECTOR SPDR TRput | $27,360,000 | +4.8% | 800,000 | -7.0% | 5.45% | +63.1% |
| ARMK | Sell | ARAMARK | $12,402,000 | -11.7% | 300,000 | -33.3% | 2.47% | +37.5% |
| ICE | Sell | INTERCONTINENTAL EXCHANGE IN | $10,259,000 | +3.2% | 100,000 | -9.1% | 2.04% | +60.7% |
| KRE | Sell | SPDR SER TRput | $5,874,000 | -80.0% | 100,000 | -80.0% | 1.17% | -68.9% |
| TPIC | Sell | TPI COMPOSITES INC | $3,042,000 | -22.9% | 300,000 | -14.3% | 0.61% | +20.0% |
| AGTC | Exit | APPLIED GENETIC TECHNOLOGIES | $0 | – | -1,225,000 | -100.0% | -0.04% | – |
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -528,104 | -100.0% | -0.05% | – |
| RPD | Exit | RAPID7 INC | $0 | – | -15,000 | -100.0% | -0.08% | – |
| Exit | DMY SQUARED TECHNOLOGY GROUPunit 99/99/9999 | $0 | – | -100,000 | -100.0% | -0.13% | – | |
| TPIC | Exit | TPI COMPOSITES INCcall | $0 | – | -150,000 | -100.0% | -0.22% | – |
| DXC | Exit | DXC TECHNOLOGY COput | $0 | – | -70,000 | -100.0% | -0.22% | – |
| EUCR | Exit | EUCRATES BIOMEDICAL ACQU COR | $0 | – | -200,000 | -100.0% | -0.26% | – |
| DXC | Exit | DXC TECHNOLOGY CO | $0 | – | -100,000 | -100.0% | -0.31% | – |
| CG | Exit | CARLYLE GROUP INC | $0 | – | -100,000 | -100.0% | -0.33% | – |
| SI | Exit | SILVERGATE CAP CORPput | $0 | – | -44,300 | -100.0% | -0.43% | – |
| BX | Exit | BLACKSTONE INC | $0 | – | -40,000 | -100.0% | -0.43% | – |
| RPD | Exit | RAPID7 INCput | $0 | – | -80,000 | -100.0% | -0.44% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -21,000 | -100.0% | -0.48% | – |
| DOCU | Exit | DOCUSIGN INCcall | $0 | – | -80,000 | -100.0% | -0.55% | – |
| SBNY | Exit | SIGNATURE BK NEW YORK N Y | $0 | – | -32,500 | -100.0% | -0.63% | – |
| DFS | Exit | DISCOVER FINL SVCS | $0 | – | -60,000 | -100.0% | -0.70% | – |
| RPD | Exit | RAPID7 INCcall | $0 | – | -142,500 | -100.0% | -0.78% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -123,100 | -100.0% | -0.85% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -130,000 | -100.0% | -0.86% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INCput | $0 | – | -200,000 | -100.0% | -0.95% | – |
| Exit | SL GREEN RLTY CORP | $0 | – | -215,000 | -100.0% | -1.10% | – | |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -19,349 | -100.0% | -1.25% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -141,000 | -100.0% | -1.49% | – |
| AMZN | Exit | AMAZON COM INC | $0 | – | -120,000 | -100.0% | -1.74% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCput | $0 | – | -200,000 | -100.0% | -1.75% | – |
| CCK | Exit | CROWN HLDGS INC | $0 | – | -171,780 | -100.0% | -1.78% | – |
| LNG | Exit | CHENIERE ENERGY INC | $0 | – | -90,975 | -100.0% | -1.93% | – |
| ANTM | Exit | ELEVANCE HEALTH INC | $0 | – | -41,012 | -100.0% | -2.38% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -300,000 | -100.0% | -3.04% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -480,500 | -100.0% | -3.31% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -245,000 | -100.0% | -8.38% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -762,500 | -100.0% | -34.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.